Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Or

Showing results (91-100 of 256) with videos related to

Pageof 26
Sort By:
Bone Marrow Transplantation|October 1, 1996
Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantationA Toren, D Novick, A Ackerstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantationR Or, P Drakos, A Nagler, et al.
Leukemia Research|October 23, 1998
The role of thiotepa in autologous bone marrow transplantation for acute leukemiaA Nagler, R Finlander, R Or, et al.
Bone Marrow Transplantation|October 1, 1992
Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomasR Or, J Mehta, E Naparstek, et al.
Leukemia Research|November 26, 1999
The role of thiotepa in allogeneic stem cell transplantation in patients with leukemiaF Rosales, E Naparstek, G Varadi, et al.
Transplantation|November 15, 1995
Elevated inflammatory cytokine levels in bone marrow graft rejectionA Nagler, R Or, B Nisman, et al.
Bone Marrow Transplantation|December 1, 1994
Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrowS Chaushu, G Chaushu, A Garfunkel, et al.
Blood|May 1, 1996
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMTS Slavin, E Naparstek, A Nagler, et al.
Medical Oncology (Northwood, London, England)|June 1, 1995
Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantationE Berman, J Kapelushnik, I Sharon, et al.
Cancer Investigation|January 1, 1992
Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokinesS Slavin, A Ackerstein, L Weiss, et al.
Pageof 26

Showing results (91-100 of 256) with videos related to

Sort By:
Pageof 26
Bone Marrow Transplantation|October 1, 1996
Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantationA Toren, D Novick, A Ackerstein, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantationR Or, P Drakos, A Nagler, et al.
Leukemia Research|October 23, 1998
The role of thiotepa in autologous bone marrow transplantation for acute leukemiaA Nagler, R Finlander, R Or, et al.
Bone Marrow Transplantation|October 1, 1992
Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomasR Or, J Mehta, E Naparstek, et al.
Leukemia Research|November 26, 1999
The role of thiotepa in allogeneic stem cell transplantation in patients with leukemiaF Rosales, E Naparstek, G Varadi, et al.
Transplantation|November 15, 1995
Elevated inflammatory cytokine levels in bone marrow graft rejectionA Nagler, R Or, B Nisman, et al.
Bone Marrow Transplantation|December 1, 1994
Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrowS Chaushu, G Chaushu, A Garfunkel, et al.
Blood|May 1, 1996
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMTS Slavin, E Naparstek, A Nagler, et al.
Medical Oncology (Northwood, London, England)|June 1, 1995
Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantationE Berman, J Kapelushnik, I Sharon, et al.
Cancer Investigation|January 1, 1992
Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokinesS Slavin, A Ackerstein, L Weiss, et al.
Pageof 26